Biobanks & Biomarkers

The field of molecular epidemiology is progressing fast, thanks to advancements in informatics and various high-throughput omics technologies.  Novel biomarkers of exposure, susceptibility and disease status provide unique opportunities in health research. Not only do they provide better understanding of disease mechanisms, but they are also valuable for disease screening and for developing dose response models. Swiss TPH researchers have established several large biobanks containing well-characterised human and non-human biospecimens. State-of-the-art infrastructure and analytical technology is available for the safe storage and efficient retrieval of these specimens and for sample analysis in the context of genomic, proteomic, lipidomic and other omic-oriented research projects.

Units doing research on this topic

All EPH units have broad expertise in this topic.